Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onicit for CINV Prevention in Colombia
NCT00684463Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Merck & Co.. Started Apr 2007; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00684463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684463.